BeStock  
Stocks › Biotechnology › OBX

Obsidian Therapeutics OBX

US equityMarket cap rank #3397Biotechnology
$13.20 −$0.02 (-0.15%)
Pre-market · Oct 8, 8:20 am ET · After hours $13.20 0.00%
Open$13.02
Prev close$13.22
Day range$12.80 – $13.88
Volume359.0K
Market cap$815.40M
P/E (TTM)20.3
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings20.3x
CheapRich

Below its usual level · 36th percentile, 5-year average 14.3x

#1608 of 2973 stocks by PE (1 = cheapest)

Price / book2.3x
CheapRich

Near the bottom of its 5-year range · 6th percentile, 5-year average 3.1x

#3235 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-29x0x29x58xAug '26Sep '26Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$16.49
Price vs. fair value-20.0%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.32 – 3.13 6% (cheaper than usual) #3235 of 5317 (1 = cheapest)
PE 20.31 -6.00 14.31 36% (cheaper than usual) #1608 of 2973 (1 = cheapest)
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$16.49
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on OBX.

Leave a comment

Scroll to Top